Differentiating COPD from Asthma in Clinical Practice

References

• . Orie NGM, Sluiter HJ, eds. Bronchitis. Assen, The Netherlands: Royal van Gorcum; 1961:43–59
   Google Scholar
• . Silva GE, Sherrill DL, Guerra S, Barbee RA. Asthma as a risk factor for COPD in a longitudinal study. Chest. 2004;126(1):59–65
   PubMed Web of Science ®Google Scholar
• . National Heart, Lung, and Blood Institute. Diseases and Condition Index. Who is at risk for asthma? www.nhlbi.nih.gov/health/dci/Diseases/Asthma/Asthma_WhoIsAtRisk.html. Accessed June 15, 2008
   Google Scholar
• . Enright PL, McClelland RL, Newman AB, Gottlieb DJ, Lebowitz MD. Underdiagnosis and undertreatment of asthma in the elderly. Chest. 1999;116(3):603–613
   PubMed Web of Science ®Google Scholar
• . Thomson NC, Chaudhuri R, Livingston E. Asthma and cigarette smoking. Eur Respir J. 2004;24(5):822–833
   PubMed Web of Science ®Google Scholar
• . Meyers DA, Postma DS, Stine OC, . Genome screen for asthma and bronchial hyperresponsiveness: interactions with passive smoke exposure. J Allergy Clin Immunol. 2005;115(6):1169–1175
   PubMedGoogle Scholar
• . Colilla S, Nicolae D, Pluzhnikov A, ; Collaborative Study for the Genetics of Asthma. Evidence for gene-environment interactions in a linkage study of asthma and smoking exposure. J Allergy Clin Immunol. 2003;111(4):840–846
   PubMedGoogle Scholar
• . Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Updated 2008. www.goldcopd.com. Accessed April 13, 2009
   Google Scholar
• . Strachan DP. Hay fever, hygiene, and household size. BMJ. 1989; 299(6710): 1259–1260
   PubMed Web of Science ®Google Scholar
• . Mannino DM, Gagnon RC, Petty TL, Lydick E. Obstructive lung disease and low lung function in adults in the United States: data from the National Health and Nutrition Examination Survey, 1988–1994. Arch Intern Med. 2000;160(11):1683–1689
   PubMed Web of Science ®Google Scholar
• . Weiss W. Cigarette smoking and lung cancer trends. Chest. 1997; 111(5): 1414–1416
   PubMedGoogle Scholar
• . Silverman EK. Genetic epidemiology of COPD. Chest. 2002;121( suppl 3):1S–6S
   PubMed Web of Science ®Google Scholar
• . Hogarth DK, Rachelefsky G. Screening and familial testing of patients alpha-1 antitrypsin deficiency. Chest. 2008;133(4):981–988
   PubMedGoogle Scholar
• . van der Pouw, Kraan TC, Küçükaycan M, . Chronic obstructive pulmonary disease is associated with the—1055 IL-13 promoter polymorphism. Genes Immun. 2002;3(7):436–439
   PubMedGoogle Scholar
• . Postma DS, Bleecker ER, Amelung PJ, . Genetic susceptibility to asthma-bronchial hyperresponsiveness coinherited with a major gene for atopy. N Engl J Med. 1995;333(14):894–900
   PubMed Web of Science ®Google Scholar
• . Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention. Updated 2008. www.ginasthma.com. Accessed April 13, 2009
   Google Scholar
• . Spencer LT, Paone G, Krein PM, . Role of human neutrophil peptides in lung inflammation associated with a1-antitrypsin deficiency. Am J Physiol Lung Cell Mol Physiol. 2004;286(3):L514–L520
   PubMed Web of Science ®Google Scholar
• . Hogg JC, Chu F, Utokaparch S, . The nature of small airways obstruction in chronic obstructive pulmonary disease. N Engl J Med. 2004;350(26):2645–2653
   PubMed Web of Science ®Google Scholar
• . Ito K, Ito M, Elliot WM, . Decreased histone deacetylase activity in chronic obstructive pulmonary disease. N Engl J Med. 2005;352(19):1967–1976
   PubMed Web of Science ®Google Scholar
• . Adcock IM, Ito K, Barnes PJ. Histone deacetylation: an important mechanism in inflammatory lung disease. COPD. 2005;2(4):445–455
   PubMedGoogle Scholar
• . Marwick JA, Ito K, Adcock IM, Kirkham PA. Oxidative stress and steroid resistance in asthma and COPD: pharmacological manipulation of HDAC-2 as a therapeutic strategy. Expert Opin Ther Targets. 2007;11(6):745–755
   PubMed Web of Science ®Google Scholar
• . Molfino M. Genetics of COPD. Chest. 2004;125(5):1929–1940
   PubMed Web of Science ®Google Scholar
• . Gelb AF, Zamel N, Krishnan A. Physiologic similarities and differences between asthma and chronic obstructive pulmonary disease. Curr Opin Pulm Med. 2008;14(1):24–30
   PubMed Web of Science ®Google Scholar
• . Wenzel SE. Asthma: defining of the persistent adult phenotypes. Lancet. 2006;368(9537):804–813
   PubMed Web of Science ®Google Scholar
• . Chaudhuri R, Livingston E, McMahon AD, Thomson L, Borland W, Thomson NC. Cigarette smoking impairs the therapeutic response to oral corticosteroids in chronic asthma. Am J Respir Crit Care Med. 2003;168(11):1308–1311
   PubMed Web of Science ®Google Scholar
• . Calverley PM, Burge PS, Spencer S, Anderson JA, Jones PW. Bronchodilator reversibility testing in chronic obstructive pulmonary disease. Thorax. 2003;58(8):659–664
   PubMed Web of Science ®Google Scholar
• . Kesten S, Rebuck AS. Is the short-term response to inhaled beta-adrenergic agonist sensitive or specific for distinguishing between asthma and COPD? Chest. 1994;105(4):1042–1045
   PubMed Web of Science ®Google Scholar
• . Price DB, Tinkelman DG, Halbert RJ, . Symptom-based questionnaire for identifying COPD in smokers. Respiration. 2006;73(3):285–295
   PubMed Web of Science ®Google Scholar
• . Tinkelman DG, Price DB, Nordyke RJ, . Symptom-based questionnaire for differentiating COPD from asthma. Respiration. 2006;73(3):296–305
   PubMed Web of Science ®Google Scholar
• . Jiva TM, Israel RH, Poe RH. Tropical pulmonary eosinophilia masquerading as acute bronchial asthma. Respiration. 1996;63(1):55–58
   PubMedGoogle Scholar
• . Vijayan VK. Tropical pulmonary eosinophilia: pathogenesis, diagnosis and management. Curr Opin Pulm Med. 2007;13(5):428–433
   PubMed Web of Science ®Google Scholar
• . US Preventive Services Task Force. Screening for chronic obstructive pulmonary disease using spirometry: US Preventive Services Task Force Recommendation Statement. Ann Intern Med. 2008;148(7):529–534
   PubMedGoogle Scholar
• . Corren J, Casale TB, Lanier B, Buhl R, Holgate S, Jiminez P. Safety and tolerability of omalizumab [published online ahead of print March 17, 2009]. Clin Exp Allergy.
   Google Scholar
• . Calverley PM, Anderson JA, Celli B, ; TORCH investigators. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med. 2008;356(8):775–789
   Google Scholar
• . Tashkin DP, Celli B, Senn S, ; UPLIFT Study Investigators. A 4-year trial of tiotropium in chronic obstructive pulmonary disease. N Engl J Med. 2008;359(15):1543–1554
   PubMed Web of Science ®Google Scholar
• . Macie, C, Wooldrage, K, Manfreda J, Anthonisen NR. Inhaled corticosteroids and mortality in COPD. Chest. 2006;130(3):640–646
   PubMed Web of Science ®Google Scholar
• . Sin DD, Tu JV. Inhaled corticosteroids and risk of mortality and readmission in elder patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2001;164(4):580–584
   PubMed Web of Science ®Google Scholar
• . Sin DD, Man SF. Inhaled corticosteroids and survival in chronic obstructive pulmonary disease: does the dose matter? Eur Respir J. 2003;21(2):260–266
   PubMedGoogle Scholar
• . Soriano JB, Kiri VA, Pride NB, Vestbo J. Inhaled corticosteroids with/without long acting agonists reduce the risk of rehospitalization and death in COPD patients. Am J Respir Med. 2003;2(1):67–74
   PubMedGoogle Scholar
• . Soriano JB, Vestbo J, Pride NB, Kiri V, Maden C, Maier WC. Survival in COPD patients after regular use of fluticasone propionate and salmeterol in general practice. Eur Respir J. 2002;20(4):819–825
   PubMed Web of Science ®Google Scholar
• . Sin DD, Man SFP, Tu JV. Inhaled glucocorticoids in COPD: immortal time bias. Am J Respir Crit Care Med. 2003;168(1):126–127
   PubMedGoogle Scholar
• . Sin DD, Paul Man SF. Cooling the fire within: inhaled corticosteroids and cardiovascular mortality in COPD. Chest. 2006;130(3):629–631
   PubMedGoogle Scholar
• . Kempainen RR, Savik K, Whelan TP, Dunitz JM, Herrington CS, Billings JL. High prevalence of proximal and distal gastroesophageal reflux disease in advanced COPD. Chest. 2007;131(6):1666–1671
   PubMedGoogle Scholar
• . Niklasson A, Strid H, Simrén M, Engström CP, Björnsson E. Prevalence of gastrointestinal symptoms in patients with chronic obstructive pulmonary disease. Eur J Gastroenterol Hepatol. 2008;20(4):335–341
   PubMedGoogle Scholar
• . Jiang SP, Huang LW. Role of gastroesophageal reflux disease in asthmatic patients. Eur Rev Med Pharmacol Sci. 2005;9(3):151–160
   PubMedGoogle Scholar
• . Dixon AE. Rhinosinusitis and asthma: the missing link. Curr Opin Pulm Med. 2009;15(1):19–24
   PubMedGoogle Scholar
• . Kim JS, Rubin BK. Nasal and sinus inflammation in chronic obstructive pulmonary disease. COPD. 2007;4(2):163–166
   PubMedGoogle Scholar
• . Celli BR, MacNee W, ATS/ERS Task Force. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J. 2004;23(6):932–946
   PubMed Web of Science ®Google Scholar
• . O'Donnell DE, Hernandez P, Kaplan A, . Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease—2008 update—highlights for primary care. Can Respir J. 2008;15( suppl A):1A–8A
   PubMed Web of Science ®Google Scholar
• . British Thoracic Society Standards of Care Committee. BTS statement on criteria for specialist referral, admission, discharge and follow-up for adults with respiratory disease. Thorax. 2008;63( suppl 1):i1–i16
   PubMedGoogle Scholar